The Lancet4h
Scaling up clinical research capacity in Africa requires more non-communicable disease studies
There is a growing opportunity to expand clinical research capacity in Africa, and numerous organisations are contributing to this effort. To name a few: the African Medicines Agency provides ...
Mayo Clinic1d
Center for Regenerative Biotherapeutics
The Mayo Clinic Center for Regenerative Biotherapeutics manufactures a wide range of products for active, early-phase clinical trials.
Tivic Health targets FDA approval for Entolimod within 18 months, highlights transformation into biopharma
Ernst emphasized the strategic transformation of Tivic into a diversified therapeutics company, combining biologic and bioelectronic approaches to address immune dysregulation. This includes ...
Healio3d
FDA approves vutrisiran for ATTR amyloidosis with cardiomyopathy
Alnylam announced the FDA approval of its supplemental new drug application for vutrisiran, an RNA interfering small molecule ...
In rare move, Syracuse’s largest nursing home opens doors to Alzheimer’s research on residents
Syracuse, NY -- Syracuse’s largest nursing home is entering a new frontier of research: allowing clinical trials on ...
Novartis4d
Novartis receives third FDA approval for oral Fabhalta® (iptacopan) – the first and only treatment approved in C3 glomerulopathy (C3G)
Novartis receives third FDA approval for oral Fabhalta® (iptacopan) – the first and only treatment approved in C3 glomerulopathy (C3G) Fabhalta is the only oral alternative complement pathway ...